Vertex Pharmaceuticals Software amortization expense remained flat by 0.0% to $7.80M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 23.8%, from $6.30M to $7.80M. Over 2 years (FY 2023 to FY 2025), Software amortization expense shows an upward trend with a 62.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Rising amortization may indicate significant past investment in digital infrastructure or IT systems.
The periodic expense recognized for the consumption of capitalized internal-use or external-use software assets. This re...
Standard operating expense for technology-reliant companies.
other_capitalized_computer_software_amortization1| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $11.80M | $25.20M | $31.20M |
| YoY Change | — | +113.6% | +23.8% |